• FirefoxInstall the new Firefox »
  •  Dow Down0.47% Nasdaq Down0.56%

    Nxstage Medical, Inc. (NXTM)

    16.66 Down 0.43(2.52%) Mar 3, 4:00PM EST
    Add to Portfolio
    ProfileGet Profile for:
    Nxstage Medical, Inc.
    350 Merrimack Street
    Lawrence, MA 01843
    United States - Map
    Phone: 978-687-4700
    Website: http://www.nxstage.com

    Index Membership:N/A
    Industry:Medical Appliances & Equipment
    Full Time Employees:3,400

    Business Summary 

    NxStage Medical, Inc., a medical device company, develops, manufactures, and markets products for the treatment of kidney failure, fluid overload, and related blood treatments and procedures. Its primary product is the NxStage System One, a portable hemodialysis system used for the treatment of acute and chronic kidney failure, and fluid overload. The company operates in two segments, System One and In-Center. The System One segment sells and rents the NxStage System One and PureFlow SL dialysate preparation equipment. This segment also sells extracorporeal disposable products, which are primarily used for in-center dialysis treatments for patients with end-stage renal disease (ESRD) in the home and critical care markets. The In-Center segment sells blood tubing sets and needles for hemodialysis primarily for the treatment of ESRD patients at dialysis centers; and needles for apheresis. NxStage Medical, Inc. markets its products through direct sales force and distributors to hospitals and dialysis centers in the United States and internationally. The company, formerly known as QB Medical, Inc., was founded in 1998 and is headquartered in Lawrence, Massachusetts.

    Key Statistics

    Company Websites 
    Home Page
    Search Yahoo! for:
    More on Nxstage Medical, Inc.

    Corporate Governance 
    Nxstage Medical, Inc.’s ISS Governance QuickScore as of Feb 1, 2015 is 5. The pillar scores are Audit: 2; Board: 4; Shareholder Rights: 5; Compensation: 7.
    Brought to you by Institutional Shareholder Services (ISS)

    Key Executives 
    Mr. Jeffrey H. Burbank , 53
    Founder, Chief Exec. Officer and Director
    Mr. Joseph E. Turk Jr., 47
    Mr. Matthew W. Towse , 52
    Chief Financial Officer, Chief Accounting Officer, Sr. VP and Treasurer
    Ms. Winifred L. Swan Esq., 51
    Sr. VP, Gen. Counsel and Sec.
    Mr. Todd M. Snell , 44
    Sr. VP of Quality Assurance, Regulatory & Clinical Affairs
    Amounts are as of Dec 31, 2013 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.
    Currency in USD.
    View Insiders